Geron reported $4.66M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Bio Techne USD 971K 386K Sep/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Cytokinetics USD 10.25M 2.75M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 15.92M 867K Sep/2025
Genmab DKK 25M 8M Jun/2025
Geron USD 4.66M 496K Jun/2025
Gilead Sciences USD 88M 15M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
MacroGenics USD 1.53M 114K Sep/2025
Novavax USD 303K 27K Dec/2021